» Articles » PMID: 15728512

IL-10 Gene-deficient Mice Lack TGF-beta/Smad Signaling and Fail to Inhibit Proinflammatory Gene Expression in Intestinal Epithelial Cells After the Colonization with Colitogenic Enterococcus Faecalis

Overview
Journal J Immunol
Date 2005 Feb 25
PMID 15728512
Citations 43
Authors
Affiliations
Soon will be listed here.
Abstract

Nonpathogenic enteric bacterial species initiate and perpetuate experimental colitis in IL-10 gene-deficient mice (IL-10(-/-)). Bacteria-specific effects on the epithelium are difficult to dissect due to the complex nature of the gut microflora. We showed that IL-10(-/-) mice compared with wild-type mice fail to inhibit proinflammatory gene expression in native intestinal epithelial cells (IEC) after the colonization with colitogenic Gram-positive Enterococcus faecalis. Interestingly, proinflammatory gene expression was transient after 1 wk of E. faecalis monoassociation in IEC from wild-type mice, but persisted after 14 wk of bacterial colonization in IL-10(-/-) mice. Accordingly, wild-type IEC expressed phosphorylated NF-kappaB subunit RelA (p65) and phosphorylated Smad2 only at day 7 after bacterial colonization, whereas E. faecalis-monoassociated IL-10(-/-) mice triggered persistent RelA, but no Smad2 phosphorylation in IEC at days 3, 7, 14, and 28. Consistent with the induction of TLR2-mediated RelA phosphorylation and proinflammatory gene expression in E. faecalis-stimulated cell lines, TLR2 protein expression was absent after day 7 from E. faecalis-monoassociated wild-type mice, but persisted in IL-10(-/-) IEC. Of note, TGF-beta1-activated Smad signaling was associated with the loss of TLR2 protein expression and the inhibition of NF-kappaB-dependent gene expression in IEC lines. In conclusion, E. faecalis-monoassociated IL-10(-/-), but not wild-type mice lack protective TGF-beta/Smad signaling and fail to inhibit TLR2-mediated proinflammatory gene expression in the intestinal epithelium, suggesting a critical role for IL-10 and TGF-beta in maintaining normal epithelial cell homeostasis in the interplay with commensal enteric bacteria.

Citing Articles

Gut microbiota in colorectal cancer development and therapy.

Wong C, Yu J Nat Rev Clin Oncol. 2023; 20(7):429-452.

PMID: 37169888 DOI: 10.1038/s41571-023-00766-x.


Compositional Changes in the Gut Microbiota of Responders and Non-responders to Probiotic Treatment Among Patients With Diarrhea-predominant Irritable Bowel Syndrome: A Post Hoc Analysis of a Randomized Clinical Trial.

Shin S, Park S, Moon J, Kim K, Kim J, Chun J J Neurogastroenterol Motil. 2022; 28(4):642-654.

PMID: 36250371 PMC: 9577570. DOI: 10.5056/jnm21202.


Bacterial Involvement in Progression and Metastasis of Adenocarcinoma of the Stomach.

Morgan A, Seely K, Hagenstein L, Florey G, Small J Cancers (Basel). 2022; 14(19).

PMID: 36230809 PMC: 9562638. DOI: 10.3390/cancers14194886.


Intestinal homeostasis and inflammation: Gut microbiota at the crossroads of pancreas-intestinal barrier axis.

Zhang Z, Tanaka I, Pan Z, Ernst P, Kiyono H, Kurashima Y Eur J Immunol. 2022; 52(7):1035-1046.

PMID: 35476255 PMC: 9540119. DOI: 10.1002/eji.202149532.


Tumor Microenvironment Shapes Colorectal Cancer Progression, Metastasis, and Treatment Responses.

Li J, Chen D, Shen M Front Med (Lausanne). 2022; 9:869010.

PMID: 35402443 PMC: 8984105. DOI: 10.3389/fmed.2022.869010.